2151-4658/asset/olbannerleft.gif?v=1&s=75d1dd4933b4687fdb365bb32190b0a4ef453ee7)
2151-4658/asset/olbannerright.gif?v=1&s=a36ba6af41bd9af370864f6461a516746a709d31)
Polymyositis/Dermatomyositis
You have full text access to this OnlineOpen article
Interstitial lung disease in polymyositis and dermatomyositis: Longitudinal evaluation by pulmonary function and radiology
Article first published online: 25 APR 2008
DOI: 10.1002/art.23571
Copyright © 2008 by the American College of Rheumatology
1529-0131a/asset/cover.gif?v=1&s=4b71f39689e424fbb0e6725b1c033cc646a4272b "Arthritis Care & Research")
Additional Information
How to Cite
Fathi, M., Vikgren, J., Boijsen, M., Tylen, U., Jorfeldt, L., Tornling, G. and Lundberg, I. E. (2008), Interstitial lung disease in polymyositis and dermatomyositis: Longitudinal evaluation by pulmonary function and radiology. Arthritis & Rheumatism, 59: 677–685. doi: 10.1002/art.23571
Publication History
- Issue published online: 25 APR 2008
- Article first published online: 25 APR 2008
- Manuscript Accepted: 2 NOV 2007
- Manuscript Received: 4 AUG 2006
Funded by
- The Swedish Rheumatism Association
- King Gustaf V's 80-Year Foundation
- The Swedish Research Council. Grant Number: 2002-74X-14045-02A
- Professor Nanna Svartz Foundation
- Karolinska Institutet Foundation
- Swedish Heart Lung Foundation
- Abstract
- Article
- References
- Cited By
Cited in:
- CrossRef
This article has been cited by:
- 1, , , , , , , , , , , Anti-MDA5 antibody, ferritin and IL-18 are useful for the evaluation of response to treatment in interstitial lung disease with anti-MDA5 antibody-positive dermatomyositis, Rheumatology, 2012,
- 2, , , Interstitial Lung Disease in Myositis: Clinical Subsets, Biomarkers, and Treatment, Current Rheumatology Reports, 2012, 14, 3, 264
- 3, , , , , Interstitial Lung Disease in the Connective Tissue Diseases, Clinics in Chest Medicine, 2012, 33, 1, 123
- 4, , , , , , Interstitial lung disease outcomes by high-resolution computed tomography (HRCT) in Anti-Jo1 antibody-positive polymyositis patients: A single centre study and review of the literature, Autoimmunity Reviews, 2012, 11, 5, 335
- 5, , , KL-6: a serological biomarker for interstitial lung disease in patients with polymyositis and dermatomyositis, Journal of Internal Medicine, 2012, 271, 6Direct Link:
- 6, , , , , Predictors of survival in a cohort of patients with polymyositis and dermatomyositis: effect of corticosteroids, methotrexate and azathioprine, Arthritis Research & Therapy, 2012, 14, 1, R22
- 7, , Treatment of interstitial lung diseases associated with connective tissue diseases, Expert Review of Clinical Pharmacology, 2012, 5, 2, 219
- 8, , Multicentric Reticulohistiocytosis with Dermatomyositis-Like Features: A More Common Disease Presentation than Previously Thought, Dermatology, 2011, 222, 2, 102
- 9, , , , , , Short-term and long-term outcomes of interstitial lung disease in polymyositis and dermatomyositis: A series of 107 patients, Arthritis & Rheumatism, 2011, 63, 11Direct Link:
- 10
- 11
- 12
- 13, , Clinical characteristics and outcomes of patients with idiopathic inflammatory myopathies from Jordan 1996–2009, Clinical Rheumatology, 2010, 29, 12, 1381
- 14, , , , , , , , , , , , Clinical manifestation and prognostic factor in anti-melanoma differentiation-associated gene 5 antibody-associated interstitial lung disease as a complication of dermatomyositis, Rheumatology, 2010, 49, 9, 1713
- 15, , , Comment traiter une myopathie inflammatoire de l’adulte ?, Revue du Rhumatisme, 2010, 77, 4, 333
- You have free access to this content16, Dermatomyositis and polymyositis, Annals of the New York Academy of Sciences, 2010, 1184, 1Direct Link:
- 17, , , , , , , , , Increased ferritin predicts development and severity of acute interstitial lung disease as a complication of dermatomyositis, Rheumatology, 2010, 49, 7, 1354
- 18, , Interstitial lung disease and idiopathic inflammatory myopathies: progress and pitfalls, Current Opinion in Rheumatology, 2010, 22, 6, 633
- 19, , , , , , , , , , , , , Long-term outcome of patients with polymyositis/ dermatomyositis and anti-PM-Scl antibody, British Journal of Dermatology, 2010, 162, 2Direct Link:
- 20, , , , , , , , Serum ferritin correlates with activity of anti-MDA5 antibody-associated acute interstitial lung disease as a complication of dermatomyositis, Modern Rheumatology, 2010, 21, 2, 223
- 21, , , , , Tratamiento secuencial de la neumonitis intersticial asociada con polimiositis, Revista de PatologÃa Respiratoria, 2010, 13, 2, 88
- 22, , , Treatment of inflammatory muscle disease in adults, Joint Bone Spine, 2010, 77, 5, 390
- 23, , , , , , Characteristics of interstitial lung disease in SS-A positive/Jo-1 positive inflammatory myopathy patients, Rheumatology International, 2009, 29, 9, 989
- 24, , , , , , , , , , , Characterization and peripheral blood biomarker assessment of anti–Jo-1 antibody–positive interstitial lung disease, Arthritis & Rheumatism, 2009, 60, 7Direct Link:
- 25, , , , , Clinical Characteristics of Patients With Anti-Jo-1 Antibodies, JCR: Journal of Clinical Rheumatology, 2009, 15, 5, 254
- 26
- 27, , , Pulmonary involvement in polymyositis and dermatomyositis, International Journal of Clinical Rheumatology, 2009, 4, 1, 45
- 28, , , , Rituximab treatment of the anti-synthetase syndrome--a retrospective case series, Rheumatology, 2009, 48, 8, 968
- 29, Autoantibodies and their significance in myositis, Current Rheumatology Reports, 2008, 10, 4, 333